Tag: medical research

Trump’s Fetal Tissue Ban Makes Good Business Sense

Dr. Warren Albrecht | United States

President Donald Trump led his administration to ban fetal tissue use in research. Both the Washington Post and New York Times immediately pointed to research from HIV to Parkinson’s as possibly being “devastated”.

“The ban on fetal tissue research is akin to a ban on hope for millions of Americans suffering from life-threatening and debilitating diseases. It will also severely impact the National Institutes of Health, universities and other researchers, who will lose key funding for their laboratories and their vital work.”

It is documented well in the book Science Left Behind that, from Bill Clinton to Obama, politicians have been trying to get around the issue of stem cell research. Originally, the issue surrounded embryos, and Congress restricted any money directly involved in their destruction. Dr. James Thomson, at the University of Wisconsin in 1998, isolated Human Embryonic Stem (hESC) cells. These cells are essentially origin cells. They can differentiate into any cell from the body. The potential for curing or treating diseases may be infinite. Dr. Thomson was funded through the Geron Corporation and Wisconsin Alumni Research Foundations. Essentially no federal government funds were used. Stem cells derived from the different tissues of a fetus became the next political battleground.

Continue reading “Trump’s Fetal Tissue Ban Makes Good Business Sense”

Advertisements

FDA Approves Ketamine-Derived Antidepressant

Benjamin Olsen | @benpleasestop

The FDA just approved a new antidepressant, the first of its kind. Unlike other antidepressants, this one is a nasal spray. Esketamine, under the brand name Spravato, is developed by Johnson & Johnson and has been in testing for the past 2 years. The drug has seen remarkable success. This success is interesting because the drug is closely tied to the club drug “Special K.” Related to MDMA, Special K is known as Ecstasy. This marks the first major breakthrough in the treatment of depression since the 1980s.

Continue reading “FDA Approves Ketamine-Derived Antidepressant”